文献速递神经头颈MR

眼部结构钆延迟渗漏:年龄及血管危险因素相关小血管病的潜在标志物?

Delayed Gadolinium Leakage in Ocular Structures: A Potential Marker for Age- and Vascular Risk Factor-Related Small Vessel Disease?
PubMed 文献 · Invest Radiol · 2021-01-01

回顾性研究纳入467例急性神经功能缺损患者,比较卒中组与卒中模拟组在注射大环状钆剂后72小时内FLAIR上眼部结构钆渗漏(GLOS)的检出率,两组相近(32.2% vs 28.9%,P=0.65);GLOS与年龄、糖尿病、严重肾功能衰竭及钆剂量独立相关,提示其可能反映年龄及血管危险因素相关小血管病所致血视网膜屏障通透性增高,而非卒中特异。

要点

  • 卒中组GLOS检出率32.2%(136/422)与卒中模拟组28.9%(13/45)相近,平均差3.3%(95%CI -10.9至17.6,P=0.65),GLOS对卒中不特异。
  • GLOS定义为随访FLAIR上玻璃体较基线平扫FLAIR出现高信号,阅片时需对比增强前图像确认。
  • 多因素分析显示年龄(P<0.001)、糖尿病(P=0.010)、严重肾功能衰竭(P=0.004)及钆剂量增加(P<0.001)为GLOS的独立影响因素。

核心结论

  • GLOS在较高钆浓度时更常见,对卒中不特异,可能代表与年龄及血管危险因素相关小血管病有关的血视网膜屏障通透性增高。

研究设计与样本

  • 回顾性研究纳入2017年7月至2018年8月连续入住卒中单元的急性神经功能缺损患者467例,均行基线脑MRI注射大环状钆剂及72小时内未注射的随访扫描。
  • 依据弥散加权成像将患者分为卒中组422例与卒中模拟组45例。
  • GLOS定义为随访FLAIR上玻璃体信号较基线(增强前)FLAIR变亮。
  • 收集临床数据及基线影像特征,包括梗死体积、低灌注体积(如适用)、白质高信号、腔隙灶数量及微出血数量,合并为小血管病评分。

关键影像表现/征象

  • GLOS表现为随访FLAIR上玻璃体较增强前基线FLAIR出现高信号。
  • 单因素分析中GLOS与年龄较大、血管危险因素患病率增高、脑影像小血管病特征(白质高信号、腔隙灶、微出血)以及肾功能受损和钆剂量增加相关。
  • GLOS与卒中相关因素(梗死体积、急性治疗、再通率)无关联。

诊断标准与关键数值

  • GLOS定义:随访FLAIR上玻璃体高信号,与基线增强前FLAIR相比。
  • 卒中组GLOS 32.2%(136/422) vs 卒中模拟组28.9%(13/45),平均差3.3%(95%CI -10.9至17.6,P=0.65)。

临床应用与阅片要点

  • 阅读增强后延迟FLAIR时,可对比增强前FLAIR评估玻璃体是否出现新发高信号以识别GLOS。
  • GLOS并非卒中特异征象,报告中不宜据此推断卒中诊断。
  • 发现GLOS时,可结合年龄、糖尿病、肾功能及钆剂量等背景信息理解其意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Gadolinium leakage in ocular structures (GLOS) was recently observed in fluid-attenuated inversion recovery (FLAIR) images obtained the day after an initial gadolinium injection in stroke patients. The specificity of GLOS to stroke and its mechanisms remain unclear.

OBJECTIVE: We investigated the factors associated with GLOS in a cohort of patients presenting with acute neurological deficits.

MATERIALS AND METHODS: This retrospective study included consecutive patients admitted to our stroke unit for acute neurological deficit between July 2017 and August 2018 who underwent baseline brain magnetic resonance imaging with the injection of a macrocyclic gadolinium agent and another scan without injection within 72 hours. The patients were separated into a stroke group and a stroke mimic group based on diffusion-weighted images. Gadolinium leakage in ocular structures was defined as a bright signal in the vitreous in follow-up FLAIR compared with baseline FLAIR (pregadolinium). Clinical data were collected together with imaging features from the baseline scans, including the volume of the infarct and of hypoperfusion if applicable, white matter hyperintensities, the number of lacunes, and the number of microbleeds, which were combined to yield a small vessel disease (SVD) score. We compared the prevalence of GLOS in both groups using the χ2 test. In the entire cohort, univariate and multivariate regression models were used to test the associations between GLOS and the collected data.

RESULTS: Among the 467 patients included in the study, GLOS was observed in similar proportions in the stroke group (32.2%, 136/422) and the stroke mimic group (28.9%, 13/45; mean difference, 3.3%; 95% confidence interval, -10.9 to 17.6; P = 0.65). In univariate analysis, GLOS was associated with older age, increased prevalence of vascular risk factors, brain imaging features of SVD (white matter hyperintensities, lacunes, microbleeds), as well as with impairment of renal function and increased dose of gadolinium. No associations were found with factors related to stroke, such as its volume, acute treatment, or rate of recanalization. Multivariate analyses showed that aging (P < 0.001), diabetes (P = 0.010), severe renal failure (P = 0.004), and increased dose of gadolinium (P < 0.001) were independent contributors to GLOS.

CONCLUSIONS: Gadolinium leakage in ocular structures, which occurs more commonly at higher concentrations of gadolinium, is not specific to stroke and may represent increased permeability of the blood-retinal barrier associated with age- and vascular risk factor-related SVD.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Galmiche C, Moal B, Marnat G, et al. Delayed Gadolinium Leakage in Ocular Structures: A Potential Marker for Age- and Vascular Risk Factor-Related Small Vessel Disease? Invest Radiol. 2021. PMID: 33481460. doi:10.1097/RLI.0000000000000757

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。